Expert opinions of the first Italian Consensus Conference on the management of malignant pleural mesothelioma

Carmine Pinto, Andrea Ardizzoni, Pier Giacomo Betta, Francesco Facciolo, Gianfranco Tassi, Sandro Tonoli, Maurizio Zompatori, Gabriele Alessandrini, Stefano Maria Magrini, Marcello Tiseo, Vita Mutri

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is a very important public health issue. A large amount of data indicates a relationship between mesothelioma and asbestos exposure. The incidence has both considerably and constantly increased over the past 2 decades in the industrialized countries and is expected to peak in 2010-2020. In Italy, a standardized-rate incidence in 2002 among men was 2.98 per 100,000 and 0.98 per 100,000 among women, with wide differences from one region to another. Stage diagnosis and definition may be difficult. Management of patients with MPM remains complex, so an optimal treatment strategy has not yet been clearly defined. The First Italian Consensus Conference on Malignant Pleural Mesothelioma was held Bologna (Italy) in May 20, 2008. The Consensus Conference was given the patronage of the Italian scientific societies AIOM, AIRO, AIPO, SIC, SICO, SICT, SIAPEC-IAP, AIOT, GOAM, and GIME. This Consensus did not answer all of the unresolved questions in MPM management, but the Expert Opinions have nonetheless provided recommendations, presented in this report, on MPM management for clinicians and patients.

Original languageEnglish
Pages (from-to)99-109
Number of pages11
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume34
Issue number1
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Expert Testimony
Italy
Asbestos
Mesothelioma
Incidence
Developed Countries
Public Health
Malignant Mesothelioma

Keywords

  • malignant pleural mesothelioma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Expert opinions of the first Italian Consensus Conference on the management of malignant pleural mesothelioma. / Pinto, Carmine; Ardizzoni, Andrea; Betta, Pier Giacomo; Facciolo, Francesco; Tassi, Gianfranco; Tonoli, Sandro; Zompatori, Maurizio; Alessandrini, Gabriele; Magrini, Stefano Maria; Tiseo, Marcello; Mutri, Vita.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 34, No. 1, 02.2011, p. 99-109.

Research output: Contribution to journalArticle

Pinto, Carmine ; Ardizzoni, Andrea ; Betta, Pier Giacomo ; Facciolo, Francesco ; Tassi, Gianfranco ; Tonoli, Sandro ; Zompatori, Maurizio ; Alessandrini, Gabriele ; Magrini, Stefano Maria ; Tiseo, Marcello ; Mutri, Vita. / Expert opinions of the first Italian Consensus Conference on the management of malignant pleural mesothelioma. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2011 ; Vol. 34, No. 1. pp. 99-109.
@article{4763ae1ac6d4434d9f686af84f76d95b,
title = "Expert opinions of the first Italian Consensus Conference on the management of malignant pleural mesothelioma",
abstract = "Malignant pleural mesothelioma (MPM) is a very important public health issue. A large amount of data indicates a relationship between mesothelioma and asbestos exposure. The incidence has both considerably and constantly increased over the past 2 decades in the industrialized countries and is expected to peak in 2010-2020. In Italy, a standardized-rate incidence in 2002 among men was 2.98 per 100,000 and 0.98 per 100,000 among women, with wide differences from one region to another. Stage diagnosis and definition may be difficult. Management of patients with MPM remains complex, so an optimal treatment strategy has not yet been clearly defined. The First Italian Consensus Conference on Malignant Pleural Mesothelioma was held Bologna (Italy) in May 20, 2008. The Consensus Conference was given the patronage of the Italian scientific societies AIOM, AIRO, AIPO, SIC, SICO, SICT, SIAPEC-IAP, AIOT, GOAM, and GIME. This Consensus did not answer all of the unresolved questions in MPM management, but the Expert Opinions have nonetheless provided recommendations, presented in this report, on MPM management for clinicians and patients.",
keywords = "malignant pleural mesothelioma",
author = "Carmine Pinto and Andrea Ardizzoni and Betta, {Pier Giacomo} and Francesco Facciolo and Gianfranco Tassi and Sandro Tonoli and Maurizio Zompatori and Gabriele Alessandrini and Magrini, {Stefano Maria} and Marcello Tiseo and Vita Mutri",
year = "2011",
month = "2",
doi = "10.1097/COC.0b013e3181d31f02",
language = "English",
volume = "34",
pages = "99--109",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Expert opinions of the first Italian Consensus Conference on the management of malignant pleural mesothelioma

AU - Pinto, Carmine

AU - Ardizzoni, Andrea

AU - Betta, Pier Giacomo

AU - Facciolo, Francesco

AU - Tassi, Gianfranco

AU - Tonoli, Sandro

AU - Zompatori, Maurizio

AU - Alessandrini, Gabriele

AU - Magrini, Stefano Maria

AU - Tiseo, Marcello

AU - Mutri, Vita

PY - 2011/2

Y1 - 2011/2

N2 - Malignant pleural mesothelioma (MPM) is a very important public health issue. A large amount of data indicates a relationship between mesothelioma and asbestos exposure. The incidence has both considerably and constantly increased over the past 2 decades in the industrialized countries and is expected to peak in 2010-2020. In Italy, a standardized-rate incidence in 2002 among men was 2.98 per 100,000 and 0.98 per 100,000 among women, with wide differences from one region to another. Stage diagnosis and definition may be difficult. Management of patients with MPM remains complex, so an optimal treatment strategy has not yet been clearly defined. The First Italian Consensus Conference on Malignant Pleural Mesothelioma was held Bologna (Italy) in May 20, 2008. The Consensus Conference was given the patronage of the Italian scientific societies AIOM, AIRO, AIPO, SIC, SICO, SICT, SIAPEC-IAP, AIOT, GOAM, and GIME. This Consensus did not answer all of the unresolved questions in MPM management, but the Expert Opinions have nonetheless provided recommendations, presented in this report, on MPM management for clinicians and patients.

AB - Malignant pleural mesothelioma (MPM) is a very important public health issue. A large amount of data indicates a relationship between mesothelioma and asbestos exposure. The incidence has both considerably and constantly increased over the past 2 decades in the industrialized countries and is expected to peak in 2010-2020. In Italy, a standardized-rate incidence in 2002 among men was 2.98 per 100,000 and 0.98 per 100,000 among women, with wide differences from one region to another. Stage diagnosis and definition may be difficult. Management of patients with MPM remains complex, so an optimal treatment strategy has not yet been clearly defined. The First Italian Consensus Conference on Malignant Pleural Mesothelioma was held Bologna (Italy) in May 20, 2008. The Consensus Conference was given the patronage of the Italian scientific societies AIOM, AIRO, AIPO, SIC, SICO, SICT, SIAPEC-IAP, AIOT, GOAM, and GIME. This Consensus did not answer all of the unresolved questions in MPM management, but the Expert Opinions have nonetheless provided recommendations, presented in this report, on MPM management for clinicians and patients.

KW - malignant pleural mesothelioma

UR - http://www.scopus.com/inward/record.url?scp=79951673779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951673779&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e3181d31f02

DO - 10.1097/COC.0b013e3181d31f02

M3 - Article

C2 - 20414089

AN - SCOPUS:79951673779

VL - 34

SP - 99

EP - 109

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -